O 2 deprivation (hypoxia) and cellular proliferation engage opposite cellular pathways, yet often coexist during tumor growth. The ability of cells to grow during hypoxia results in part …
Oncogenic KRAS is the key driver of pancreatic ductal adenocarcinoma (PDAC). We previously described a role for KRAS in PDAC tumor maintenance through rewiring of …
PC Fernandez, SR Frank, L Wang… - Genes & …, 2003 - genesdev.cshlp.org
The transcription factor Myc is induced by mitogenic signals and regulates downstream cellular responses. If overexpressed, Myc promotes malignant transformation. Myc …
O Vafa, M Wade, S Kern, M Beeche, TK Pandita… - Molecular cell, 2002 - cell.com
Oncogene overexpression activates p53 by a mechanism posited to involve uncharacterized hyperproliferative signals. We determined whether such signals produce metabolic …
X-ray structures of the basic/helix-loop-helix/leucine zipper (bHLHZ) domains of Myc-Max and Mad-Max heterodimers bound to their common DNA target (Enhancer or E box …
The interaction of MYC and hypoxia inducible factors (HIFs) under physiological, non- tumorigenic conditions provides insights into normal homeostatic cellular responses to low …
Abstract c-MYC is the prototype for oncogene activation by chromosomal translocation. In contrast to the tightly regulated expression of c-myc in normal cells, c-myc is frequently …
P Staller, K Peukert, A Kiermaier, J Seoane, J Lukas… - Nature cell …, 2001 - nature.com
Deregulated expression of c-myc can induce cell proliferation in established cell lines and in primary mouse embryonic fibroblasts (MEFs), through a combination of both transcriptional …
X Yin, C Giap, JS Lazo, EV Prochownik - Oncogene, 2003 - nature.com
Abstract c-Myc is helix–loop–helix–leucine zipper (HLH–ZIP) oncoprotein that is frequently deregulated in human cancers. In order to bind DNA, regulate target gene expression, and …